Contemporary treatment of Western and Chinese medicine for cardiac syndrome X.
10.1007/s11655-011-0714-2
- Author:
Ying-Fei BI
1
;
Jing-Yuan MAO
;
Xian-Liang WANG
;
Heng-He WANG
;
Yong-Bin GE
;
Zhen-Peng ZHANG
Author Information
1. Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Integrative Medicine;
Medicine, Chinese Traditional;
Metabolic Syndrome;
physiopathology;
therapy;
Quality of Life
- From:
Chinese journal of integrative medicine
2011;17(4):314-320
- CountryChina
- Language:English
-
Abstract:
Clinical reports on cardiac syndrome X (CSX) have been increasing in recent years. In general, CSX does not increase the cardiovascular mortality, but it can affect the patient's quality of life (QOL) and increase the incidence rates of cardiovascular and cerebrovascular events. Although a variety of drugs and therapies have been utilized in the clinical treatment, the management of CSX still represents a major challenge due to its unclear pathogenesis. It is necessary to explore more effective treatment programs. Many attempts have been made on trials of the Chinese medicine (CM) treatment for CSX and proved that CM has a certain advantage in efficacy to improve clinical symptoms and QOL. CM may provide a new approach for the effective treatment of CSX.
